WB001 to Treat Mild to Moderate Postpartum Depression
May 1, 2022 | Technology Forecasts
Preview
WB001 is a digital therapeutic being investigated to treat mild to moderate postpartum depression.
Postpartum depression is a major depressive episode that begins in late pregnancy or within 4 weeks of delivery. Current treatments can be cost prohibitive or difficult to access. WB001 might help reduce postpartum depressive symptoms, in part by increasing patient access to treatment, because it can be used at home or wherever patients can access their phones. ...